None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are currently receiving or have received chemotherapy that induces chemotherapy-induced peripheral neuropathy (CIPN) . 2. Patients who are capable of understanding the study and voluntarily consenting to participate, with the ability to communicate verbally.
Exclusion criteria
Exclusion criteria: 1. Patients who are unable to perform activities without a caregiver. 2. Patients with a history of severe mental disorders. 3. Patients with lesions on their hands or feet not related to chemotherapy. 4. Patients with coagulation due to bleeding in their hands or feet. 5. Patients with terminal cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity Assessment (Visual Analogue Scale: VAS);CIPN Symptom Assessment Tool (EORTC QLQ-CIPN20) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI);Quality of Life Assessment (Functional Assessment of Cancer Therapy-General, FACT-G) | — |
Countries
Korea, Republic of
Contacts
CHA University